EUVIMEDEUVIMED entdecken
Open Access

Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience

Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, Karthik V Giridhar, Roberto A Leon-Ferre, Amye J Tevaarwerk, Elizabeth Cathcart-Rake, Ciara C O'Sullivan, Prema P Peethambaram, Timothy J Hobday, Lida A Mina, Felipe Batalini und 7 weitere

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2024.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Nusrat Jahan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL; Department of Oncology, Mayo Clinic, Rochester, MN. Electro…. Hauptthemen laut MEDLINE: Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Practice Patterns, Physicians'. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS, Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsPractice Patterns, Physicians'HumansFemaleMiddle AgedPhthalazinesAgedAdultPiperazinesRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

OlaparibTalazoparib

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPhthalazinesolaparibtalazoparibPiperazines

Autor:innen und Institutionen

  • Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL; Department of Oncology, Mayo Clinic, Rochester, MN. Electronic address: njahan@uabmc.edu.
  • Department of Oncology, Mayo Clinic, Rochester, MN.
  • Department of Quantitative Health Services, Mayo Clinic, Rochester, MN.
  • Department of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ.
  • Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS
  • Mayo Clinic

Zitieren

APA

Jahan, N., Taraba, J., Boddicker, N. J., Giridhar, K. V., Leon-Ferre, R. A., Tevaarwerk, A. J., Cathcart-Rake, E., O'Sullivan, C. C., Peethambaram, P. P., Hobday, T. J., Mina, L. A., Batalini, F., Advani, P., Sideras, K., Haddad, T. C., Ruddy, K. J., Goetz, M. P., Couch, F. J., & Yadav, S. (2025). Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.10.006

Vancouver

Jahan N, Taraba J, Boddicker NJ, Giridhar KV, Leon-Ferre RA, Tevaarwerk AJ, et al. Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.10.006

BibTeX
@article{Jahan2025,
  author = {Jahan, Nusrat and Taraba, Jodi and Boddicker, Nicholas J and Giridhar, Karthik V and Leon-Ferre, Roberto A and Tevaarwerk, Amye J and Cathcart-Rake, Elizabeth and O'Sullivan, Ciara C and Peethambaram, Prema P and Hobday, Timothy J and Mina, Lida A and Batalini, Felipe and Advani, Pooja and Sideras, Kostandinos and Haddad, Tufia C and Ruddy, Kathryn J and Goetz, Matthew P and Couch, Fergus J and Yadav, Siddhartha},
  title = {Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2024.10.006}
}
Kostenlos starten →